Last edition
News about Market
Dr Lal PathLabs Q4 net profit dips 31% to Rs. 32.6 crore
Dr Lal PathLabs Limited, a leading diagnostic and related healthcare service provider posted 31% dip in net profit at Rs. 32.6 crore for the fourth quarter ended March 31, 2020 as compared to Rs. 47.4 crore in Q4 last year
Market | 19/05/2020 | By Darshana | 375
Roche today announced that new data from clinical trials of 19 approved and investigational medicines across 21 cancer types, will be presented at the ASCO20 Virtual Scientific Program organised by the American Society of Clinical Oncology (ASCO), which will be held 29-31 May, 2020
Market | 08/05/2020 | By Darshana | 363
IIT Guwahati collaborates with Hester Biosciences Limited to develop vaccine against COVID-19
Indian Institute of Technology Guwahati is collaborating with Hester Biosciences Limited, a pharmaceutical company based in Ahmedabad, Gujarat, to work on the vaccine development against COVID-19. The agreement between the two parties was signed on 15th April 2020
Market | 29/04/2020 | By Darshana | 269
Syngene International opens COVID-19 RT-PCR testing centre to support Bengaluru hospitals
Syngene International Ltd., a global research and development services company, today announced the opening of a COVID-19 testing laboratory at its Bengaluru site. In less than six weeks, the company used its expertise in clinical trial management
Market | 28/04/2020 | By Darshana | 265
Today, the U.S. Food and Drug Administration granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with triple-negative breast cancer that has spread to other parts of the body. Patients must have received at least two prior therapies before taking Trodelvy
Market | 25/04/2020 | By Darshana | 468
Uber partners Medlife to ensure medicine deliveries across 5 cities
As our battle as a people against COVID-19 intensifies, and stricter norms get put in place to flatten the curve, it is crucial that we all stay at home, and that we stay healthy while at home
Market | 19/04/2020 | By Darshana | 242
Lupin's Mandideep Unit II Facility Receives EIR from U.S. FDA
Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) after closure of the U.S. FDA inspection of its Mandideep Unit II facility, classifying the inspection as Voluntary Action Indicated. The inspection at the facility was carried out by the U.S. FDA between November 26, 2018 and December 4, 2018
Market | 15/04/2020 | By Darshana | 232
BELLUS Health Inc, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that it has entered into an asset purchase and sale agreement to acquire all of the remaining BLU-5937 and related P2X3 antagonists intellectual property assets.
Market | 24/03/2020 | By Darshana | 495
Sun Pharma Launches RIOMET ER Oral Suspension in the U.S.
Sun Pharmaceutical Industries Ltd. today announced that one of its wholly-owned subsidiaries has launched Riomet ER in the U.S. as an adjunct to diet and exercise to improve glycemic control in patients 10 years of age and older with type 2 diabetes mellitus. Riomet ER was approved by the U.S. Food and Drug Administration (FDA) on August 29, 2019
Market | 14/03/2020 | By Darshana | 244
India curbs key drug exports as worldwide coronavirus scare grows
India, the world's main supplier of generic drugs, has restricted the export of 26 pharmaceutical ingredients and the medicines made from them, including Paracetamol, a common pain reliever also sold as acetaminophen, as the coronavirus outbreak plays havoc with supply chains
Market | 12/03/2020 | By Darshana | 717
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy